why choose us

First received: January 23, 2025

Clinical Trial: Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Substance Use Disorder (SUD)
Alcohol Use Disorder (AUD)
Nicotine Addiction
Healthy Ad

Study Type: INTERVENTIONAL


Official Title: Metabolomic and Gut Microbial Biomarkers of Smoking Cessation Treatment in Long-term Drug Therapy: A Randomized Controlled Trial

Brief Summary: Theoretical Framework: Cigarette smoking is the leading preventable cause of death worldwide, with nicotine dependence notably common among individuals with Substance Use Disorders (SUD). Smoking exacerbates both physical and mental health issues, further complicating the treatment of SUD. Current therapeutic approaches for SUD often prove inadequate, indicating a need for new strategies. Recent advancements in metabolomics and gut microbiome research have provided valuable insights into the biological mechanisms…

Read more